Chesapeake Wealth Management Danaher Corp Transaction History

Chesapeake Wealth Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 23, 2023	SELL	$241.42 - $282.29 $30,177 - $35,286	-125 Reduced 14.01%	767 $203,000
Q3 2022 Oct 28, 2022	SELL	$247.06 - $1507.4 $25,941 - $158,277	-105 Reduced 10.53%	892 $230,000
Q2 2022 Jul 21, 2022	SELL	$237.11 - $299.66 $5,927 - $7,491	-25 Reduced 2.45%	997 $253,000
Q1 2022 Apr 19, 2022	SELL	$257.27 - $315.76 $12,863 - $15,788	-50 Reduced 4.66%	1,022 $300,000
Q4 2021 Feb 03, 2022	SELL	$292.08 - $329.01 $20,445 - $23,030	-70 Reduced 6.13%	1,072 $353,000
Q3 2021 Oct 26, 2021	SELL	$272.21 - $332.43 $29,943 - $36,567	-110 Reduced 8.79%	1,142 $348,000
Q2 2021 Jul 29, 2021	SELL	$225.08 - $271.69 $22,508 - $27,169	-100 Reduced 7.4%	1,252 $336,000
Q1 2021 Apr 26, 2021	SELL	$212.38 - $245.9 $55,218 - $63,934	-260 Reduced 16.13%	1,352 $304,000
Q4 2020 Feb 05, 2021	SELL	$212.5 - $245.46 $143,437 - $165,685	-675 Reduced 29.51%	1,612 $358,000
Q3 2020 Nov 12, 2020	SELL	$177.16 - $215.33 $24,448 - $29,715	-138 Reduced 5.69%	2,287 $492,000
Q2 2020 Aug 11, 2020	SELL	$128.7 - $176.83 $32,561 - $44,737	-253 Reduced 9.45%	2,425 $429,000
Q1 2020 Apr 29, 2020	SELL	$121.39 - $169.05 $72,955 - $101,599	-601 Reduced 18.33%	2,678 $371,000
Q4 2019 Jan 29, 2020	SELL	$133.47 - $153.48 $422,566 - $485,917	-3,166 Reduced 49.12%	3,279 $503,000
Q3 2019 Oct 25, 2019	BUY	$135.4 - $146.47 $133,775 - $144,712	988 Added 18.11%	6,445 $931,000
Q2 2019 Aug 01, 2019	BUY	$124.88 - $143.73 $681,470 - $784,334	5,457 New	5,457 $780,000

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.